Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
TIVC Quote, Financials, Valuation and Earnings
Last price:
$4.08
Seasonality move
:
-47.61%
Day range:
$3.91 - $4.08
52-week range:
$2.43 - $16.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.35x
P/B ratio:
1.26x
Volume:
13.5K
Avg. volume:
22.3K
1-year change:
-36.44%
Market cap:
$3.8M
Revenue:
$780K
EPS (TTM):
-$14.52
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Tivic Health Systems has -- downside to fair value with a price target of -- per share.
TIVC vs. S&P 500
-
Over the past 5 trading days, Tivic Health Systems has underperformed the S&P 500 by -9.37% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Tivic Health Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tivic Health Systems revenues have been falling on a year-over-year basis for 9 quarters in a row. In the most recent quarter Tivic Health Systems reported revenues of $70K.
Earnings Growth
-
Tivic Health Systems has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Tivic Health Systems reported earnings per share of -$2.52.
Enterprise value:
3.1M
EV / Invested capital:
--
Price / LTM sales:
3.35x
EV / EBIT:
--
EV / Revenue:
6.09x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.57x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$115K
Return On Assets:
-157.26%
Net Income Margin (TTM):
-1100%
Return On Equity:
-192.41%
Return On Invested Capital:
-192.41%
Operating Margin:
-2151.43%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.8M | $1.1M | $516K | $334K | $70K | |
| Gross Profit | $344K | $341K | -$115K | $167K | $50K | |
| Operating Income | -$10M | -$7.6M | -$5.7M | -$1.5M | -$1.5M | |
| EBITDA | -$9.8M | -$7.4M | -$5.4M | -$1.4M | -$1.5M | |
| Diluted EPS | -$1,578.28 | -$190.04 | -$14.52 | -$17.15 | -$2.52 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $12M | $6.5M | $2.8M | $1.3M | |
| Total Assets | -- | $12.7M | $7.1M | $3.3M | $3.8M | |
| Current Liabilities | -- | $1.1M | $1.6M | $992K | $741K | |
| Total Liabilities | -- | $1.6M | $1.9M | $1.1M | $741K | |
| Total Equity | -- | $11.1M | $5.2M | $2.2M | $3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.2M | -$7.8M | -$4.9M | -$1.7M | -$889K | |
| Cash From Investing | -$99K | -$24K | -$526K | -- | -$526K | |
| Cash From Financing | $3.6M | $4.3M | $4.5M | -$61K | $82K | |
| Free Cash Flow | -$9.3M | -$7.8M | -$5.5M | -$1.7M | -$1.4M | |
TIVC
Sector
Market Cap
$3.8M
$34.4M
Price % of 52-Week High
24.54%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-133.67%
-1.01%
1-Year Price Total Return
-36.44%
-37.36%
Beta (5-Year)
--
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.09
200-day SMA
Sell
Level
$4.62
Bollinger Bands (100)
Sell
Level
3.2 - 5.38
Chaikin Money Flow
Buy
Level
13.4K
20-day SMA
Sell
Level
$3.96
Relative Strength Index (RSI14)
Sell
Level
47.58
ADX Line
Buy
Level
16.71
Williams %R
Neutral
Level
-71.7246
50-day SMA
Sell
Level
$4.05
MACD (12, 26)
Buy
Level
1.10
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
14.4K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-19.8505)
Sell
CA Score
(Annual)
Level (-5.5679)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (2)
Sell
Ohlson Score
Level (38.7084)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body’s own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Stock Forecast FAQ
In the current month, TIVC has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TIVC average analyst price target in the past 3 months is --.
-
Where Will Tivic Health Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tivic Health Systems share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Tivic Health Systems?
Analysts are divided on their view about Tivic Health Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tivic Health Systems is a Sell and believe this share price will rise from its current level to --.
-
What Is Tivic Health Systems's Price Target?
The price target for Tivic Health Systems over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TIVC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tivic Health Systems is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of TIVC?
You can purchase shares of Tivic Health Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tivic Health Systems shares.
-
What Is The Tivic Health Systems Share Price Today?
Tivic Health Systems was last trading at $4.08 per share. This represents the most recent stock quote for Tivic Health Systems. Yesterday, Tivic Health Systems closed at $3.95 per share.
-
How To Buy Tivic Health Systems Stock Online?
In order to purchase Tivic Health Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
